Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125474161 | 12547416 | 1 | I | 20160629 | 20160711 | 20160711 | EXP | US-APOTEX-2016AP009684 | APOTEX | CAROWAY M, SCOTT J, THAKAR CV.. MECHANISMS OF RHABDOMYOLYSIS INDUCED AKI IN THE INTENSIVE CARE UNIT: A CASE SERIES.. AM-J-KIDNEY-DIS. 2016;67(5):A31 | 80.00 | YR | M | Y | 0.00000 | 20160711 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125474161 | 12547416 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Unknown | UNK, UNKNOWN | Y | 65384 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125474161 | 12547416 | 1 | Helicobacter infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125474161 | 12547416 | HO |
| 125474161 | 12547416 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125474161 | 12547416 | Acute kidney injury | |
| 125474161 | 12547416 | Drug interaction | |
| 125474161 | 12547416 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |